INJ - ONCHAIN METRICS | Injective INJ Price Prediction
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 16 Oct 2026, 11:15 UTC
- Recorded by Tahlil Plus
- 16 Oct 2026, 13:22 UTC
AI-generated source summary
The analysis focuses on the Injective Protocol (INJ) and its price action against USDT. The current price is around $9.28, with a target price of $15.0. The fail-bound, which would invalidate the bullish setup, is set at $7.0. The overall market sentiment for INJ is bullish, with the trade expected to unfold over the coming weeks. The analysis also touches upon the broader crypto market sentiment by referencing the Bitcoin Dominance chart and the total crypto market cap excluding Bitcoin and Ethereum. A decreasing USDT dominance (from above 10% to below 4%) is interpreted as bullish for altcoins, suggesting that capital is flowing out of stablecoins and into riskier assets within the crypto market. The chart of total crypto market cap excluding BTC and ETH shows a similar bullish trajectory, indicating a potential altcoin season. However, the primary focus remains on INJ's potential upside, supported by historical patterns observed in altcoin market cycles and dominance charts, suggesting a strong upcoming bullish trend for INJ and altcoins in general.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.